Top Story

New specialty designation marks major advance for interventional cardiology

January 29, 2015

It is difficult to briefly summarize the field of interventional cardiology today. From the time of its inception in 1977, interventional cardiologists could offer angioplasty to select patients with coronary disease with only the few options of balloon catheters based on limited studies and mostly anecdotal experience. Fast-forward to 2015 and it is clear that the knowledge base and expertise required to truly understand interventional cardiology have exploded in the manner of Moore’s law for computers.

In addition to coronary atherosclerosis, interventional cardiologists are now consulted to assess transcatheter options for cardiac assist devices, peripheral arterial and venous disease, valvular heart disease, thromboembolic venous disorders, congenital heart disease and lesions of exceeding complexity, such as chronic total occlusions, to name just a few. As a field, interventional cardiology has created one of the most prolific stockpiles of evidence-based medicine, with large randomized trials, registries and quality improvement measures continually altering our daily practice.

In the JournalsPerspective

New permanent pacemaker implantation after TAVR linked to worse clinical outcomes

January 29, 2015
In the PARTNER trial and registry, 8.8% of patients who underwent transcatheter aortic valve replacement with a balloon-expandable valve required new permanent pacemaker…
In the Journals

Implementation of new hypertension guidelines projected to prevent 13,000 annual CV deaths

January 28, 2015
Implementation of the 2014 guidelines of the Eighth Joint National Committee on hypertension for US adults could prevent 13,000 annual CV deaths and 56,000 CV events…
In the Journals

CABG linked to better outcomes than PCI, but at higher price

January 28, 2015
Patients who underwent CABG had improved outcomes at 4 years but at a higher overall cost compared with PCI, according to results of a cost-effectiveness analysis of the…
FDA approvals

Percutaneous VAD for right heart support receives FDA approval

January 28, 2015
The FDA has approved under a Humanitarian Device Exemption the first single-access percutaneous ventricular assist device for right heart support, according to a press…
More News Headlines »
CME
Risk Management in the Cardiovascular Disease Arena

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »
Meeting News Coverage Video
thumbnail for video 3945938325001

Kirk N. Garratt, MD: Prolonged DAPT beneficial in patients with paclitaxel-eluting stents

December 16, 2014
CHICAGO — In this video, Kirk N. Garratt, MD, of the Lennox Hill Hospital, New York, outlines results of a study…
More »
CME
Obesity Consults: Volume 2, Number 1

Obesity Consults: Volume 2, Number 1

This activity is supported by an educational grant from Vivus, Inc.

Obesity is suboptimally managed in clinical practice despite the availability of relevantguidelines and evidence-based…
More »
morganatic-roan
morganatic-roan